By now, we all know that spending too much time staring at screens – be it computers, phones, iPads – plays havoc with sleep. But do you know why?
Researchers have pinpointed how certain cells in the eye process ambient light and reset our internal clocks, the daily cycles of physiological processes known as the circadian rhythm. When these cells are exposed to artificial light late into the night, our internal clocks can get confused, resulting in a host of health issues.
The study, conducted by Salk Institute researchers, has been published in the journal Cell Reports.
The results may help lead to new treatments for migraines, insomnia, jet lag and circadian rhythm disorders, which have been tied to cognitive dysfunction, cancer, obesity, insulin resistance, metabolic syndrome and more.
The backs of our eyes contain a sensory membrane called the retina, whose innermost layer contains a tiny subpopulation of light-sensitive cells that operate like pixels in a digital camera.
When these cells are exposed to ongoing light, a protein called melanopsin continually regenerates within them, signaling levels of ambient light directly to the brain to regulate consciousness, sleep and alertness.
Melanopsin plays a pivotal role in synchronising our internal clock after 10 minutes of illumination and, under bright light, suppresses the hormone melatonin, responsible for regulating sleep.
In the new work, the Salk researchers used molecular tools to turn on production of melanopsin in retinal cells in mice.
They discovered that some of these cells have the ability to sustain light responses when exposed to repeated long pulses of light, while others become desensitised.
Conventional wisdom has held that proteins called arrestins, which stop the activity of certain receptors, should halt cells’ photosensitive response within seconds of lights coming on.
The researchers were surprised to find that arrestins are in fact necessary for melanopsin to continue responding to prolonged illumination.
In mice lacking either version of the arrestin protein (beta arrestin 1 and beta arrestin 2), the melanopsin-producing retinal cells failed to sustain their sensitivity to light under prolonged illumination. The reason, it turns out, is that arrestin helps melanopsin regenerate in the retinal cells.
By better understanding the interactions of melanopsin in the body and how the eyes react to light, researchershope to find new targets to counter skewed circadian rhythms due to, for example, artificial illumination.
Previously, the research team discovered that chemicals called opsinamides could block melanopsin’s activity in mice without affecting their vision, offering a potential therapeutic avenue to address hypersensitivity to light experienced by migraine sufferers. (ANI)
